Proventys

Proventys was a healthcare informatics company that developed a proprietary clinical decision support platform designed to enable personalized medicine. The company's primary focus was on oncology, where it collaborated with the National Comprehensive Cancer Network (NCCN) to integrate evidence-based guidelines into a digital point-of-care tool for clinicians. By providing real-time, patient-specific treatment recommendations, Proventys aimed to improve clinical outcomes and standardize high-quality care. The company was acquired by McKesson in 2011 to enhance its specialty health and oncology offerings. Following the acquisition, its technology was integrated into McKesson's suite of provider and payer solutions to support value-based care initiatives.